Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
AUNA
Valuation N/A
AUNA S.A.
Price$5.17
Model IV—
P/IV—
AUPH
Deeply undervalued
Aurinia Pharmaceuticals Inc.
Price$16.10
Model IV$42.74
P/IV0.36
Discount 62%
Return to IV: +165.5%
Market implies +4.8%/yr
vs model +25.0% · below model
AUR
Valuation N/A
Aurora Innovation, Inc.
Price$6.43
Model IV—
P/IV—
Market implies +150.0%/yr
vs model +2.0% · above model
AURA
Valuation N/A
Aura Biosciences, Inc.
Price$7.00
Model IV—
P/IV—
AURE
Valuation N/A
Aurelion Inc.
Price$1.44
Model IV—
P/IV—
Market implies +41.0%/yr
vs model +2.0% · above model
AUROW
Valuation N/A
Aurora Innovation, Inc.
Price$0.07
Model IV—
P/IV—
Market implies +57.2%/yr
vs model +2.0% · above model
AUSI
Valuation N/A
AURA SYSTEMS INC
Price$0.18
Model IV—
P/IV—
Market implies +23.4%/yr
vs model +29.1% · below model
AUST
Valuation N/A
Austin Gold Corp.
Price$1.15
Model IV—
P/IV—
AUTL
Valuation N/A
Autolus Therapeutics plc
Price$1.94
Model IV—
P/IV—
Market implies +34.2%/yr
vs model +15.0% · above model
AUUD
Valuation N/A
AUDDIA INC.
Price$0.98
Model IV—
P/IV—
AVA
Deeply undervalued
AVISTA CORP
Price$36.79
Model IV$68.09
P/IV0.61
Discount 46%
Return to IV: +85.1%
AVAH
Undervalued
Aveanna Healthcare Holdings, Inc.
Price$14.08
Model IV$9.50
P/IV0.75
Premium +48%
Return to IV: -32.5%
Market implies +12.7%/yr
vs model +10.6% · in line
AVAL
Valuation N/A
Grupo Aval Acciones Y Valores S.A.
Price$5.35
Model IV—
P/IV—
AVAV
Valuation N/A
AeroVironment Inc
Price$146.71
Model IV—
P/IV—
Market implies +24.2%/yr
vs model +20.1% · above model
AVB
Deeply undervalued
AVALONBAY COMMUNITIES INC
Price$68.14
Model IV$98.64
P/IV1.85
Discount 31%
Return to IV: +44.8%
AVBC
Deeply overvalued
Avidia Bancorp, Inc.
Price$21.77
Model IV$12.86
P/IV1.48
Premium +69%
Return to IV: -40.9%
AVBH
Deeply overvalued
Avidbank Holdings, Inc.
Price$31.82
Model IV$19.75
P/IV1.56
Premium +61%
Return to IV: -37.9%
AVBP
Valuation N/A
ArriVent BioPharma, Inc.
Price$28.57
Model IV—
P/IV—
AVD
Deeply overvalued
AMERICAN VANGUARD CORP
Price$2.26
Model IV$1.13
P/IV2.28
Premium +100%
Return to IV: -50.0%
Market implies +10.2%/yr
vs model +3.0% · above model
AVEX
Valuation N/A
AEVEX Corp.
Price$16.08
Model IV—
P/IV—
AVGO
Valuation N/A
Broadcom Inc.
Price$357.61
Model IV—
P/IV—
Market implies +32.6%/yr
vs model +23.5% · above model
AVIR
Valuation N/A
Atea Pharmaceuticals, Inc.
Price$5.31
Model IV—
P/IV—
Market implies -2.4%/yr
vs model +15.0% · below model
AVK
Valuation N/A
ADVENT CONVERTIBLE & INCOME FUND
Price$12.23
Model IV—
P/IV—
AVLN
Valuation N/A
Avalyn Pharma Inc.
Price$33.57
Model IV—
P/IV—
AVNS
Deeply overvalued
AVANOS MEDICAL, INC.
Price$24.99
Model IV$9.19
P/IV2.70
Premium +172%
Return to IV: -63.2%
Owner yield 4.1%
10-yr IRR 6.3% · moderate
Market implies +19.1%/yr
vs model +7.4% · above model
AVNT
Deeply overvalued
AVIENT CORP
Price$41.41
Model IV$19.94
P/IV1.78
Premium +108%
Return to IV: -51.8%
Owner yield 3.6%
10-yr IRR 1.6% · steady
Market implies +12.9%/yr
vs model +3.0% · above model
AVNW
Deeply undervalued
AVIAT NETWORKS, INC.
Price$19.78
Model IV$57.83
P/IV0.31
Discount 66%
Return to IV: +192.4%
Market implies -19.3%/yr
vs model +12.1% · below model
AVO
Deeply overvalued
Mission Produce, Inc.
Price$13.01
Model IV$6.71
P/IV1.66
Premium +94%
Return to IV: -48.5%
Market implies +13.8%/yr
vs model +8.0% · above model
AVPT
Deeply overvalued
AvePoint, Inc.
Price$12.66
Model IV$5.58
P/IV1.96
Premium +127%
Return to IV: -55.9%
Market implies +25.8%/yr
vs model +18.7% · above model
AVR
Valuation N/A
Anteris Technologies Global Corp.
Price$8.35
Model IV—
P/IV—
Market implies +117.9%/yr
vs model +2.0% · above model
AVT
Fairly valued
AVNET INC
Price$99.63
Model IV$94.90
P/IV0.92
Premium +5%
Return to IV: -4.7%
Owner yield 0.5%
10-yr IRR -16.0% · moderate
Market implies +6.8%/yr
vs model +7.4% · in line
AVTR
Deeply overvalued
Avantor, Inc.
Price$14.81
Model IV$7.83
P/IV1.16
Premium +89%
Return to IV: -47.1%
Owner yield 6.3%
10-yr IRR 9.0% · steady
Market implies +11.6%/yr
vs model +3.0% · above model
AVTX
Valuation N/A
Avalo Therapeutics, Inc.
Price$16.12
Model IV—
P/IV—
Market implies +142.3%/yr
vs model +2.0% · above model
AVX
Valuation N/A
AVAX ONE TECHNOLOGY LTD.
Price$3.93
Model IV—
P/IV—
Market implies +150.0%/yr
vs model +27.8% · above model
AVXL
Valuation N/A
ANAVEX LIFE SCIENCES CORP.
Price$2.44
Model IV—
P/IV—
AVY
Valuation N/A
Avery Dennison Corp
Price$167.71
Model IV—
P/IV—
Owner yield 5.1%
10-yr IRR 6.0% · steady
Market implies +5.0%/yr
vs model +3.0% · in line
AWF
Valuation N/A
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC
Price$9.96
Model IV—
P/IV—
AWI
Fairly valued
ARMSTRONG WORLD INDUSTRIES INC
Price$163.87
Model IV$145.87
P/IV1.08
Premium +12%
Return to IV: -11.0%
Owner yield 2.7%
10-yr IRR 4.3% · moderate
Market implies +11.1%/yr
vs model +11.7% · in line
AWK
Overvalued
American Water Works Company, Inc.
Price$135.90
Model IV$112.67
P/IV1.09
Premium +21%
Return to IV: -17.1%
AWP
Valuation N/A
abrdn Global Premier Properties Fund
Price$11.15
Model IV—
P/IV—
AWR
Deeply overvalued
AMERICAN STATES WATER CO
Price$86.45
Model IV$58.50
P/IV1.48
Premium +48%
Return to IV: -32.3%
AWRE
Deeply overvalued
AWARE INC /MA/
Price$1.24
Model IV$0.63
P/IV2.41
Premium +97%
Return to IV: -49.2%
Market implies +3.9%/yr
vs model +2.0% · in line
AWX
Deeply overvalued
AVALON HOLDINGS CORP
Price$2.66
Model IV$1.38
P/IV1.84
Premium +93%
Return to IV: -48.1%
AX
Overvalued
Axos Financial, Inc.
Price$93.75
Model IV$73.46
P/IV1.18
Premium +28%
Return to IV: -21.6%
AXG
Valuation N/A
Solowin Holdings, Ltd.
Price$2.13
Model IV—
P/IV—
Market implies +48.8%/yr
vs model +2.0% · above model
AXGN
Deeply overvalued
Axogen, Inc.
Price$42.16
Model IV$11.62
P/IV3.40
Premium +263%
Return to IV: -72.4%
Market implies +13.2%/yr
vs model +15.3% · in line
AXIA
Valuation N/A
AXIA Energia S.A.
Price$9.53
Model IV—
P/IV—
AXIL
Deeply overvalued
Axil Brands, Inc.
Price$6.17
Model IV$1.52
P/IV4.41
Premium +305%
Return to IV: -75.3%
Market implies +18.1%/yr
vs model +5.0% · above model
AXIN
Valuation N/A
Axiom Intelligence Acquisition Corp 1
Price$10.34
Model IV—
P/IV—
AXINR
Valuation N/A
Axiom Intelligence Acquisition Corp 1
Price$0.34
Model IV—
P/IV—
AXINU
Valuation N/A
Axiom Intelligence Acquisition Corp 1
Price$10.73
Model IV—
P/IV—
AXON
Valuation N/A
AXON ENTERPRISE, INC.
Price$447.76
Model IV—
P/IV—
Market implies +26.2%/yr
vs model +34.0% · below model
AXP
Deeply undervalued
AMERICAN EXPRESS CO
Price$311.56
Model IV$512.26
P/IV0.62
Discount 39%
Return to IV: +64.4%
Owner yield 6.9%
10-yr IRR 18.3% · grower
Market implies +3.3%/yr
vs model +12.9% · below model
AXR
Fairly valued
AMREP CORP.
Price$22.94
Model IV$21.81
P/IV1.15
Premium +5%
Return to IV: -4.9%
Owner yield 7.1%
10-yr IRR 12.3% · steady
Market implies +2.8%/yr
vs model +5.1% · in line
AXS
Fairly valued
AXIS CAPITAL HOLDINGS LTD
Price$98.24
Model IV$107.07
P/IV0.89
Discount 8%
Return to IV: +9.0%
AXSM
Valuation N/A
Axsome Therapeutics, Inc.
Price$220.75
Model IV—
P/IV—
Market implies +18.8%/yr
vs model +15.0% · above model
AXTA
Overvalued
Axalta Coating Systems Ltd.
Price$33.29
Model IV$26.35
P/IV1.17
Premium +26%
Return to IV: -20.8%
Owner yield 6.1%
10-yr IRR 9.4% · steady
Market implies +6.8%/yr
vs model +4.1% · in line
AXTI
Valuation N/A
AXT INC
Price$64.77
Model IV—
P/IV—
Market implies +87.2%/yr
vs model +2.0% · above model
AYA
Valuation N/A
Aya Gold & Silver Inc.
Price$27.97
Model IV—
P/IV—
AYI
Fairly valued
ACUITY INC. (DE)
Price$318.96
Model IV$280.34
P/IV1.09
Premium +14%
Return to IV: -12.1%
Owner yield 5.3%
10-yr IRR 12.9% · moderate
Market implies +11.2%/yr
vs model +11.2% · in line
